Zobrazeno 1 - 10
of 499
pro vyhledávání: '"Ross A. Baker"'
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-11 (2019)
Abstract Background Although patients with dementia frequently experience neuropsychological symptoms (NPS) such as agitation, which profoundly impacts patients, caregivers, and the healthcare system, few studies have evaluated the associated burden
Externí odkaz:
https://doaj.org/article/c8d9453dfc9847b9af2f43fdce7da4fc
Autor:
Joseph R. Calabrese, Na Jin, Brian Johnson, Pedro Such, Ross A. Baker, Jessica Madera, Peter Hertel, Jocelyn Ottinger, Joan Amatniek, Hiroaki Kawasaki
Publikováno v:
International Journal of Bipolar Disorders, Vol 6, Iss 1, Pp 1-10 (2018)
Abstract Background The long-acting injectable antipsychotic aripiprazole once-monthly 400 mg (AOM 400) was recently approved for maintenance treatment of bipolar I disorder (BP-I). The purpose of this study was to evaluate the safety, tolerability,
Externí odkaz:
https://doaj.org/article/21408d497c3b417693fa2e3361884e5b
Autor:
Chris Ward, Nicola Curry, Magdy El-Ekiaby, Kerstin Jurk, Henri H. Versteeg, Charithani Keragala, Tal Burstyn-Cohen, Silvio Antoniak, Yuko Suzuki, Ross I. Baker, Olivier Christophe, Shoshana Revel-Vilk, Alice Hart, Carsten Deppermann, Huyen Tran, Nicola Pozzi, Walter H.A. Kahr, Steven P. Grover, Philip Wenzel, Ashley C. Brown, Cécile Oury, Susan M. Shea, James Fredenburgh, Freda H. Passam, James Winearls, Hunter B. Moore, Soumitra Tole, Eileen Merriman, Geoffrey D. Barnes, Z. Leonardo Liu, Michelle Sholzberg, José Rivera, Ana Marín-Quilez
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 5, Pp 102498- (2024)
Externí odkaz:
https://doaj.org/article/423f0865a53343d687904a487723fe50
Autor:
Bruce D. Wines, Halina M. Trist, Sandra Esparon, Rachael E. Impey, Graham A. Mackay, Robert K. Andrews, Tatiana P. Soares da Costa, Geoffrey A. Pietersz, Ross I. Baker, P. Mark Hogarth
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
FcγR activity underpins the role of antibodies in both protective immunity and auto-immunity and importantly, the therapeutic activity of many monoclonal antibody therapies. Some monoclonal anti-FcγR antibodies activate their receptors, but the pro
Externí odkaz:
https://doaj.org/article/c9b14b59d6114647912e69dcf8f997d5
Autor:
James S. O'Donnell, Ross I. Baker
Publikováno v:
Hämostaseologie. 43:044-051
von Willebrand disease (VWD) represents the most common inherited bleeding disorder. The majority of VWD cases are characterized by partial quantitative reductions in plasma von Willebrand factor (VWF) levels. Management of patients with mild to mode
Autor:
Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, Yi Lin Lee, Jameela Sathar, Simon McRae, Amanda Davis, Jennifer Curnow, Robert Bird, Philip Choi, Pantep Angchaisuksiri, Sim Leng Tien, Joyce Ching Mei Lam, Doyeun Oh, Jin Seok Kim, Sung-Soo Yoon, Raymond Siu-Ming Wong, Carolyn Lauren, Eileen Grace Merriman, Anoop Enjeti, Mark Smith, Ross Ian Baker
Publikováno v:
Blood Research. 58:36-41
Autor:
Helen Fogarty, Soracha E. Ward, Liam Townsend, Ellie Karampini, Stephanie Elliott, Niall Conlon, Jean Dunne, Rachel Kiersey, Aifric Naughton, Mary Gardiner, Mary Byrne, Colm Bergin, Jamie M. O'Sullivan, Ignacio Martin-Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J.S. Preston, Aisling M. Rehill, Ross I. Baker, Cliona Ni Cheallaigh, James S. O'Donnell, Niamh O’Connell, Kevin Ryan, Dermot Kenny, Judicael Fazavana
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:2429-2438
Prolonged recovery is common after acute SARS-CoV-2 infection; however, the pathophysiological mechanisms underpinning Long COVID syndrome remain unknown. VWF/ADAMTS-13 imbalance, dysregulated angiogenesis, and immunothrombosis are hallmarks of acute
Publikováno v:
Drugs in Context, Pp 1-8 (2016)
Schizophrenia presents a substantial clinical and economic burden to the health-care system. In QUAlity of LIfe with AbiliFY Maintena (QUALIFY), a randomized head-to-head study of aripiprazole once-monthly 400 mg (AOM 400) compared with paliperidone
Externí odkaz:
https://doaj.org/article/3e604f008d544801a3b160b6bf45b225
Autor:
Michelle Lavin, Maha Othman, James S. O’Donnell, Rezan Abdul-Kadir, Peter A. Kouides, Analía Sánchez Luceros, Ross I. Baker, Sandra L. Haberichter
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:82-91
Background The management of pregnant women with von Willebrand Disease (VWD) is complex as physiological pregnancy-induced increases in plasma von Willebrand Factor (VWF) may be blunted or absent. Women with VWD experience a heightened risk of postp
Autor:
Helen Fogarty, Liam Townsend, Hannah Morrin, Azaz Ahmad, Claire Comerford, Ellie Karampini, Hanna Englert, Mary Byrne, Colm Bergin, Jamie M. O’Sullivan, Ignacio Martin‐Loeches, Parthiban Nadarajan, Ciaran Bannan, Patrick W. Mallon, Gerard F. Curley, Roger J.S. Preston, Aisling M. Rehill, Dennis McGonagle, Cliona Ni Cheallaigh, Ross I. Baker, Thomas Renné, Soracha E. Ward, James S. O’Donnell, Niamh O’Connell, Kevin Ryan, Dermot Kenny, Judicael Fazavana
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Persistent symptoms including breathlessness, fatigue, and decreased exercise tolerance have been reported in patients after acute SARS-CoV-2 infection. The biological mechanisms underlying this “long COVID” syndrome remain unknown. Ho